Ironwood Pharma (IRWD) Posts Mixed Q1 Results

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.25 million versus the consensus estimate of $9.48 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Adobe Systems (ADBE) Tops Q3 EPS by 6c, Offers Guidance
• Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip